SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018594
Filing Date
2023-11-09
Accepted
2023-11-09 16:25:30
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20230930x10q.htm   iXBRL 10-Q 1344985
2 EX-31.1 gbio-20230930xex31d1.htm EX-31.1 7623
3 EX-31.2 gbio-20230930xex31d2.htm EX-31.2 8140
4 EX-32.1 gbio-20230930xex32d1.htm EX-32.1 5112
5 EX-32.2 gbio-20230930xex32d2.htm EX-32.2 5091
  Complete submission text file 0001558370-23-018594.txt   5067284

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20230930.xsd EX-101.SCH 34040
7 EX-101.CAL gbio-20230930_cal.xml EX-101.CAL 34915
8 EX-101.DEF gbio-20230930_def.xml EX-101.DEF 152555
9 EX-101.LAB gbio-20230930_lab.xml EX-101.LAB 270579
10 EX-101.PRE gbio-20230930_pre.xml EX-101.PRE 235657
51 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230930x10q_htm.xml XML 757062
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 231392958
SIC: 2834 Pharmaceutical Preparations